Main Background
True Leukocyte-Poor PRP Kit
True Leukocyte-Poor PRP Kit

Clinical-grade kit true LP-PRP kit with >90% WBC reduction and >90% platelet recovery

Clinical-grade kit true LP-PRP kit with >90% WBC reduction and >90% platelet recovery

Clinical-grade kit true LP-PRP kit with >90% WBC reduction and >90% platelet recovery

Download brochure
Download brochure
Download brochure

Tubex® Max Plus - at a Glance

Tubex® Max Plus - at a Glance

Tubex® Plus is a closed, sterile, single-use system engineered to prepare Leukocyte-Poor Platelet-Rich Plasma (LP-PRP) from whole blood in just 15 minutes.


Using a patented vortex-based design and leucocyte reduction filter, it delivers a high-concentrate, low-inflammatory PRP

Tubex® Plus is a closed, sterile, single-use system engineered to prepare Leukocyte-Poor Platelet-Rich Plasma (LP-PRP) from whole blood in just 15 minutes.


Using a patented vortex-based design and leucocyte reduction filter, it delivers a high-concentrate, low-inflammatory PRP

Tubex® Plus eliminates WBCs through proprietary filters by size-based exclusion unlocking pure regenerative potential of PRP without inflammatory interference.

Tubex® Plus eliminates WBCs through proprietary filters by size-based exclusion unlocking pure regenerative potential of PRP without inflammatory interference.

Produces 4–10 mL of true LP-PRP from 25-50ml blood.

Delivers consistent and reproducible results

Eliminates pro-inflammatory WBC seen in standard PRP systems.

Designed for superior clinical outcomes with minimal complexity.

Tubex® Plus - at a Glance

Tubex® Plus is a closed, sterile, single-use system engineered to prepare Leukocyte-Poor Platelet-Rich Plasma (LP-PRP) from whole blood in just 15 minutes.


Using a patented vortex-based design and leucocyte reduction filter, it delivers a high-concentrate, low-inflammatory PRP

Tubex® Plus eliminates WBCs through proprietary filters by size-based exclusion unlocking pure regenerative potential of PRP without inflammatory interference.

Produces 4–10 mL of true LP-PRP from 25-50ml blood.

Delivers consistent and reproducible results

Eliminates pro-inflammatory WBC seen in standard PRP systems.

Designed for superior clinical outcomes with minimal complexity.

Key Features

Card Image
Leukocyte reduction filter

Selectively traps leukocytes through size-based exclusion

Card Image
Leukocyte reduction filter

Selectively traps leukocytes through size-based exclusion

Card Image
Vortex-Based Separation

Preserves platelet integrity & growth factors

Card Image
High Platelet Recovery

Recovers >90% of platelets from each draw.

Card Image
Low Coefficient of Variation

<15% variability across kits

Card Image
Sterile, Closed System

0% contamination, single-use

Card Image
Inbuilt RBC Locking System

<1% red cell contamination

Key Features
Card Image
Leukocyte reduction filter

Selectively traps leukocytes through size-based exclusion

Card Image
Leukocyte reduction filter

Selectively traps leukocytes through size-based exclusion

Card Image
Vortex-Based Separation

Preserves platelet integrity & growth factors

Card Image
High Platelet Recovery

Recovers >90% of platelets from each draw.

Card Image
High Platelet Recovery

Recovers >90% of platelets from each draw.

Card Image
Low Coefficient of Variation

<5% variability across kits

Card Image
Low Coefficient of Variation

<5% variability across kits

Card Image
Sterile, Closed System

0% contamination, single-use

Card Image
Sterile, Closed System

0% contamination, single-use

Card Image
Inbuilt RBC Locking System

<1% red cell contamination

Core Differentiator

Core Differentiator

Enhanced pain relief – long term benefit in OA patients.

Clinically tested – validated in multiple peer-reviewed studies ¹˒²˒³˒⁴⋅

Scientifically validated – outcome consistency backed by data ¹˒²˒³˒⁴⋅

Reduced inflammation swelling– improves patient satification

Why This Matters Clinically?

For years, PRP researchers debated whether white blood cells (WBCs) inside PRP enhanced healing or triggered harmful inflammation. Recent evidence is clear: the clinical effect depends on the indication.

Orthopaedic OA: Leukocyte-poor PRP (LP-PRP) consistently shows better outcomes in knee osteoarthritis, reducing inflammatory cascades and achieving 70–85% clinical success rates【1】.

Tendinopathy: Both leukocyte-rich and leukocyte-poor PRP have been used, but LP-PRP demonstrates cleaner safety and tolerability profiles【2】.

Aesthetics: LP-PRP is superior for collagen remodelling and dermal rejuvenation, with reduced swelling and post-treatment downtime【3】.

Reproductive Medicine: LP-PRP improves endometrial receptivity and implantation rates by minimizing inflammatory microenvironment【4】.

Wound Care: In chronic wounds such as diabetic foot ulcers, LP-PRP prevents inflammatory overload and accelerates closure【5】.

Why This Matters Clinically?

For years, PRP researchers debated whether white blood cells (WBCs) inside PRP enhanced healing or triggered harmful inflammation. Recent evidence is clear: the clinical effect depends on the indication.

Orthopaedic OA: Leukocyte-poor PRP (LP-PRP) consistently shows better outcomes in knee osteoarthritis, reducing inflammatory cascades and achieving 70–85% clinical success rates【1】.

Tendinopathy: Both leukocyte-rich and leukocyte-poor PRP have been used, but LP-PRP demonstrates cleaner safety and tolerability profiles【2】.

Aesthetics: LP-PRP is superior for collagen remodelling and dermal rejuvenation, with reduced swelling and post-treatment downtime【3】.

Reproductive Medicine: LP-PRP improves endometrial receptivity and implantation rates by minimizing inflammatory microenvironment【4】.

Wound Care: In chronic wounds such as diabetic foot ulcers, LP-PRP prevents inflammatory overload and accelerates closure【5】.

Why This Matters Clinically?

For years, PRP researchers debated whether white blood cells (WBCs) inside PRP enhanced healing or triggered harmful inflammation. Recent evidence is clear: the clinical effect depends on the indication.

Orthopaedic OA: Leukocyte-poor PRP (LP-PRP) consistently shows better outcomes in knee osteoarthritis, reducing inflammatory cascades and achieving 70–85% clinical success rates【1】.

Tendinopathy: Both leukocyte-rich and leukocyte-poor PRP have been used, but LP-PRP demonstrates cleaner safety and tolerability profiles【2】.

Aesthetics: LP-PRP is superior for collagen remodelling and dermal rejuvenation, with reduced swelling and post-treatment downtime【3】.

Reproductive Medicine: LP-PRP improves endometrial receptivity and implantation rates by minimizing inflammatory microenvironment【4】.

Wound Care: In chronic wounds such as diabetic foot ulcers, LP-PRP prevents inflammatory overload and accelerates closure【5】.

Tubex® Plus vs. The Rest
 What Doctors Need to Know

Tubex® Plus vs. The Rest
 What Doctors Need to Know
Parameter

Tubex® Plus

Standard PRP Kits

Gel Separator

Parameter

TriPReP® Tubex®

PRP

Gel or Test Tubes  

Other

Commercial Kit

Proprietary Filter Technology

The total amount of cloud storage space allocated for your files.

Present

Absent

Absent

Exclusive Filter Technology

The total amount of cloud storage space allocated for your files.

Present

Absent

Absent

Platelet concentration

The speed at which you can upload and download files to and from the cloud.

~7-8x

~2.5-4x

~1.5-2x

WBC Reduction

The largest file size you can upload in a single action.

>90%

~40–50%

~60–70%

Platelet Recovery

The total amount of cloud storage space allocated for your files.

>90%

~60-70%

~20-25%

Output Volume

The speed at which you can upload and download files to and from the cloud.

4–10 ml LP-PRP

2-5ml

1–3 mL

Blood Volume

The largest file size you can upload in a single action.

25-50ml

10-30ml

10ml

RBC locking

Manage access with a specified number of user accounts per plan.

Present

Varies

Absent

Closed system

Manage access with a specified number of user accounts per plan.

Yes

Partially closed

Partially closed

Potential Indication

  • Knee Osteoarthritis

  • Acne Scars

  • Under Eye Rejenuvation

  • Plantar fascitis

Answers to Common Questions

Answers to Common Questions

We’ve gathered the most frequently asked questions to help you better understand our AI services, pricing, and integration process.

We’ve gathered the most frequently asked questions to help you better understand our AI services, pricing, and integration process.

Support Avatar

Need more help?

We're here to answer any questions you may have.

Ask a Question

Support Avatar

Need more help?

We're here to answer any questions you may have.

Ask a Question

How does Tubex® Plus differ from standard PRP kit?
How many PRP sessions are usually needed?
What clinical success rates can I expect?
How long does the PRP procedure take?
Is special equipment required?
Can I use Tubex® Plus across different specialties?
Is PRP therapy safe?
Are there contraindications?
How much PRP is produced per kit?
How does Tubex® Plus prevent RBC contamination?
How does LP-PRP compare to steroids or surgery?

How does Tubex® Plus differ from standard PRP kit?

How many PRP sessions are usually needed?

What clinical success rates can I expect?

How long does the PRP procedure take?

Is special equipment required?

Can I use Tubex® Plus across different specialties?

Is PRP therapy safe?

Are there contraindications?

How much PRP is produced per kit?

How does Tubex® Plus prevent RBC contamination?

How does LP-PRP compare to steroids or surgery?

References

References

1. Lana JF, et al. Intra-articular injections of platelet-rich plasma in knee osteoarthritis: a systematic review and meta-analysis of randomized clinical trials. Arthroscopy. 2019;35(5):1588–1601.

2. Andia I, Maffulli N. Biological therapies for tendon repair: a critical perspective. Br Med Bull. 2015;113(1):73–84. DOI:10.1093/bmb/ldu039

3. Alves R, Grimalt R. Platelet-rich plasma in dermatology: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2018;32(12):2264–2273. DOI:10.1111/jdv.15132

4. Chang Y, et al. Autologous platelet-rich plasma infusion improves endometrial receptivity in patients with recurrent implantation failure: a randomized controlled trial. Fertil Steril. 2019;111(3):564–573.

5. Carter MJ, et al. The clinical efficacy of autologous platelet-rich plasma in chronic nonhealing wounds: a systematic review and meta-analysis. Adv Skin Wound Care. 2020;33(2):84–96. DOI:10.1097/01.ASW.0000646903.20246.54

Bring the Future of Regenerative Medicine to Your Patients — Today.

Request

a Demo

Get Started

Cta Image
Cta Image

Bring the Future of Regenerative Medicine to Your Patients — Today.

Request

a Demo

Get Started

Cta Image
Cta Image

Bring the Future of Regenerative Medicine to Your Patients — Today.

Request

a Demo

Get Started

Explore products

Create a free website with Framer, the website builder loved by startups, designers and agencies.